Showing results (21-30 of 387) with videos related to
Sort By:
Pageof 39
European Heart Journal|December 1, 1991
Strategies for pre-hospital thrombolysis: an overviewM J Bouten, M L SimoonsNederlands Tijdschrift Voor Geneeskunde|December 18, 1998
[Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO]M L Simoons, A F CasparieEuropean Heart Journal|November 1, 1995
Thrombolytic therapy for evolving myocardial infarction needs an approach that integrates benefit and riskA E Arnold, M L SimoonsActa Cardiologica|September 9, 1999
Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol"J W Jukema, M L SimoonsEuropean Heart Journal|May 15, 2001
Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?B A van Hout, M L SimoonsEuropean Heart Journal|November 1, 1995
Costs and effects of c7E3 in high risk PTCA patients. An indirect analysis for The NetherlandsB A van Hout, M L SimoonsNederlands Tijdschrift Voor Geneeskunde|March 5, 1999
[Abciximab: a new antiplatelet agent for use in coronary angioplasty]M J van den Brand, M L SimoonsHerz|February 1, 1983
Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shockM L Simoons, G Muskens, P G HugenholtzEuropean Heart Journal|June 1, 1991
Cost-utility analysis of thrombolytic therapyM L Simoons, J Vos, L L MartensThe International Journal of Health Planning and Management|July 1, 1991
Hospital management: integrating the dual hierarchy?J PoolPageof 39